drugset / Trial / NCT00566891
Safety of High-dose Tirofiban During Coronary Angioplasty
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This single-centre study is intended to retrospectively check the safety of high-dose bolus of tirofiban in patients who underwent percutaneous angioplasty.
Timeline
- Start
- 2007-12
- Primary completion
- 2008-07
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | — | — |
| Comparator | Tirofiban | Other / unclassified | 0.15 ug/kg | — |